Profitable companies tend to be more resilient, giving them the flexibility to invest and return capital to shareholders.
Businesses that consistently generate earnings can better navigate downturns and capitalize on new opportunities.
The U.S. healthcare sector has entered 2026 on a remarkably strong footing, staging a decisive rebound after a tumultuous 2025. This resurgence is being driven by a rare alignment of legislative progress and pharmaceutical innovation. On January 8, 2026, the U.S. House of Representatives passed a crucial bill
For the past two years, the U.S. healthcare sector has been the forgotten stepchild of the equity markets. As the S&P 500 (SPX) surged on the back of an artificial intelligence gold rush and a resilient tech economy, healthcare investors were left nursing a "double-digit hangover." In 2024,
As the 44th Annual J.P. Morgan Healthcare Conference kicked off this week in San Francisco, all eyes turned to UnitedHealth Group (NYSE:UNH), the diversified healthcare giant that serves as the primary barometer for the multi-trillion-dollar U.S. medical sector. On January 12, 2026, the company issued a critical
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
The S&P 500 climbed to a fresh all-time high on Wednesday, January 7, 2026, as investors cheered a combination of fiscal stimulus tailwinds and the accelerating commercialization of "Agentic AI." The benchmark index surged 1.2% during the session, briefly touching an intraday peak of 7,624.88 before
As the first week of 2026 draws to a close, a distinct shift in market leadership has become the defining story for Wall Street. After a multi-year period where technology and artificial intelligence infrastructure captured the lion's share of investor attention, the healthcare sector has emerged as the unexpected powerhouse
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Today, December 22, 2025, marks the end of a tumultuous era for one of the most controversial public listings in recent memory. MSP Recovery, Inc. (Nasdaq: MSPR), which rebranded as LifeWallet during its peak, has officially been suspended from the Nasdaq Capital Market. Following a final, unsuccessful appeal to the
The Nasdaq Composite (IXIC) has been on a rollercoaster ride as 2025 draws to a close, experiencing a notable three-day losing streak before showing a modest rebound on December 17. This recent volatility has ignited discussions around an "AI bubble" and raised questions about the sustainability of the tech sector's
December S&P 500 E-Mini futures (ESZ25) are trending up +0.27% this morning as investors continue to digest the latest U.S. jobs data, while also awaiting remarks from Federal Reserve officials and an earnings report from semiconductor giant Micron.
Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately -
over the past six months, healthcare stocks have gained 14.1%, nearly mirrorring the S&P 500.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
